- Home
- BDTX vs VXRT Comparison
BDTX vs VXRT Comparison
Compare BDTX & VXRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BDTX
- VXRT
- Stock Information
- Founded
- BDTX 2014
- VXRT N/A
- Country
- BDTX United States
- VXRT United States
- Employees
- BDTX N/A
- VXRT N/A
- Industry
- BDTX Biotechnology: Biological Products (No Diagnostic Substances)
- VXRT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BDTX Health Care
- VXRT Health Care
- Exchange
- BDTX Nasdaq
- VXRT Nasdaq
- Market Cap
- BDTX 132.5M
- VXRT 119.0M
- IPO Year
- BDTX 2020
- VXRT N/A
- Fundamental
- Price
- BDTX $2.41
- VXRT $0.49
- Analyst Decision
- BDTX Strong Buy
- VXRT Strong Buy
- Analyst Count
- BDTX 5
- VXRT 2
- Target Price
- BDTX $15.60
- VXRT $3.00
- AVG Volume (30 Days)
- BDTX 1.4M
- VXRT 9.4M
- Earning Date
- BDTX 08-05-2025
- VXRT 08-07-2025
- Dividend Yield
- BDTX N/A
- VXRT N/A
- EPS Growth
- BDTX N/A
- VXRT N/A
- EPS
- BDTX 0.09
- VXRT N/A
- Revenue
- BDTX $70,000,000.00
- VXRT $47,395,000.00
- Revenue This Year
- BDTX N/A
- VXRT N/A
- Revenue Next Year
- BDTX N/A
- VXRT N/A
- P/E Ratio
- BDTX $27.30
- VXRT N/A
- Revenue Growth
- BDTX N/A
- VXRT 433.43
- 52 Week Low
- BDTX $1.20
- VXRT $0.29
- 52 Week High
- BDTX $6.75
- VXRT $1.07
- Technical
- Relative Strength Index (RSI)
- BDTX 57.88
- VXRT 52.96
- Support Level
- BDTX $2.15
- VXRT $0.54
- Resistance Level
- BDTX $2.71
- VXRT $0.60
- Average True Range (ATR)
- BDTX 0.17
- VXRT 0.08
- MACD
- BDTX -0.01
- VXRT -0.00
- Stochastic Oscillator
- BDTX 55.36
- VXRT 38.13
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.
About VXRT Vaxart Inc
Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically all the business activity functions through the region of the United States.